Glooko, the maker of a digital platform for managing diabetes and other chronic diseases, announced today a $30 million Series D funding round led by Health Catalyst Capital. Canaan Partners, Georgian, Novo Nordisk, Insulet and Mayo Clinic also played a part in the raise.
WHAT IT DOES
The Palo Alto startup's app-based platform acts as a central hub for connected monitoring devices and other...
This morning, Forward Health, a tech-heavy doctor's office founded and backed by ex-Googlers, announced a $225 million Series D funding round. Founders Fund, Khosla Ventures, SoftBank Vision Fund 2, Marc Benioff and The Weeknd each participated in the raise, along with other unnamed backers.
WHAT IT DOES
San Francisco-based Forward was formed about five years ago by Adrian Aoun (who also founded...
Yesterday Cognito Therapeutics, a startup using visual and auditory stimulation to treat neurodegenerative disorders, announced Phase 2 trial results suggesting its gamma frequency neuromodulation therapy slowed declines in memory and cognition among mild-to-moderate Alzheimer's disease patients.
The OVERTURE study, a multi-center, randomized controlled trial, enrolled 76 such patients aged 50...
Abbott announced today that it has updated NeuroSphere, its app-driven neuromodulation therapy platform, with remote programming capabilities that will allow patients to speak with and receive adjustments from their provider via a cellular or WiFi connection.
The NeuroSphere Virtual Clinic was recently approved by the FDA and is now available within the Abbott patient controller app for use with...
In December, Highmark Health announced a six-year collaboration with Google Cloud that the companies said would lay down the infrastructure of the integrated delivery network's data-driven Living Health Dynamic Platform.
Today, the organizations unveiled plans to get Verily and its Onduo chronic care subsidiary in on the action as well. Through another six-year partnership, the partners will work...
